Skip to main content
Top
Published in: Critical Care 6/2011

Open Access 01-12-2011 | Research

Risk factors for invasive fungal disease in critically ill adult patients: a systematic review

Authors: Hannah Muskett, Jason Shahin, Gavin Eyres, Sheila Harvey, Kathy Rowan, David Harrison

Published in: Critical Care | Issue 6/2011

Login to get access

Abstract

Introduction

Over 5,000 cases of invasive Candida species infections occur in the United Kingdom each year, and around 40% of these cases occur in critical care units. Invasive fungal disease (IFD) in critically ill patients is associated with increased morbidity and mortality at a cost to both the individual and the National Health Service. In this paper, we report the results of a systematic review performed to identify and summarise the important risk factors derived from published multivariable analyses, risk prediction models and clinical decision rules for IFD in critically ill adult patients to inform the primary data collection for the Fungal Infection Risk Evaluation Study.

Methods

An internet search was performed to identify articles which investigated risk factors, risk prediction models or clinical decisions rules for IFD in critically ill adult patients. Eligible articles were identified in a staged process and were assessed by two investigators independently. The methodological quality of the reporting of the eligible articles was assessed using a set of questions addressing both general and statistical methodologies.

Results

Thirteen articles met the inclusion criteria, of which eight articles examined risk factors, four developed a risk prediction model or clinical decision rule and one evaluated a clinical decision rule. Studies varied in terms of objectives, risk factors, definitions and outcomes. The following risk factors were found in multiple studies to be significantly associated with IFD: surgery, total parenteral nutrition, fungal colonisation, renal replacement therapy, infection and/or sepsis, mechanical ventilation, diabetes, and Acute Physiology and Chronic Health Evaluation II (APACHE II) or APACHE III score. Several other risk factors were also found to be statistically significant in single studies only. Risk factor selection process and modelling strategy also varied across studies, and sample sizes were inadequate for obtaining reliable estimates.

Conclusions

This review shows a number of risk factors to be significantly associated with the development of IFD in critically ill adults. Methodological limitations were identified in the design and conduct of studies in this area, and caution should be used in their interpretation.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Lamagni TL, Evans BG, Shigematsu M, Johnson EM: Emerging trends in the epidemiology of invasive mycoses in England and Wales (1990-9). Epidemiol Infect 2001, 126: 397-414.PubMedCentralCrossRefPubMed Lamagni TL, Evans BG, Shigematsu M, Johnson EM: Emerging trends in the epidemiology of invasive mycoses in England and Wales (1990-9). Epidemiol Infect 2001, 126: 397-414.PubMedCentralCrossRefPubMed
3.
go back to reference Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB: Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004, 39: 309-317. 10.1086/421946CrossRefPubMed Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB: Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004, 39: 309-317. 10.1086/421946CrossRefPubMed
5.
go back to reference Kibbler CC, Seaton S, Barnes RA, Gransden WR, Holliman RE, Johnson EM, Perry JD, Sullivan DJ, Wilson JA: Management and outcome of bloodstream infections due to Candida species in England and Wales. J Hosp Infect 2003, 54: 18-24. 10.1016/S0195-6701(03)00085-9CrossRefPubMed Kibbler CC, Seaton S, Barnes RA, Gransden WR, Holliman RE, Johnson EM, Perry JD, Sullivan DJ, Wilson JA: Management and outcome of bloodstream infections due to Candida species in England and Wales. J Hosp Infect 2003, 54: 18-24. 10.1016/S0195-6701(03)00085-9CrossRefPubMed
6.
go back to reference Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, Herwaldt L, Pfaller M, Diekema D: Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 2003, 37: 1172-1177. 10.1086/378745CrossRefPubMed Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, Herwaldt L, Pfaller M, Diekema D: Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 2003, 37: 1172-1177. 10.1086/378745CrossRefPubMed
7.
go back to reference Pittet D, Li N, Woolson RF, Wenzel RP: Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. Clin Infect Dis 1997, 24: 1068-1078. 10.1086/513640CrossRefPubMed Pittet D, Li N, Woolson RF, Wenzel RP: Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. Clin Infect Dis 1997, 24: 1068-1078. 10.1086/513640CrossRefPubMed
8.
go back to reference Jacobs S, Price Evans DA, Tariq M, Al Omar NF: Fluconazole improves survival in septic shock: a randomized double-blind prospective study. Crit Care Med 2003, 31: 1938-1946. 10.1097/01.CCM.0000074724.71242.88CrossRefPubMed Jacobs S, Price Evans DA, Tariq M, Al Omar NF: Fluconazole improves survival in septic shock: a randomized double-blind prospective study. Crit Care Med 2003, 31: 1938-1946. 10.1097/01.CCM.0000074724.71242.88CrossRefPubMed
9.
go back to reference Garbino J, Lew DP, Romand JA, Hugonnet S, Auckenthaler R, Pittet D: Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med 2002, 28: 1708-1717. 10.1007/s00134-002-1540-yCrossRefPubMed Garbino J, Lew DP, Romand JA, Hugonnet S, Auckenthaler R, Pittet D: Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med 2002, 28: 1708-1717. 10.1007/s00134-002-1540-yCrossRefPubMed
10.
go back to reference Sandven P, Qvist H, Skovlund E, Giercksky KE, NORGAS Group and the Norwegian Yeast Study Group: Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations. Crit Care Med 2002, 30: 541-547. 10.1097/00003246-200203000-00008CrossRefPubMed Sandven P, Qvist H, Skovlund E, Giercksky KE, NORGAS Group and the Norwegian Yeast Study Group: Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations. Crit Care Med 2002, 30: 541-547. 10.1097/00003246-200203000-00008CrossRefPubMed
11.
go back to reference Pelz RK, Hendrix CW, Swoboda SM, Diener-West M, Merz WG, Hammond J, Lipsett PA: Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg 2001, 233: 542-548. 10.1097/00000658-200104000-00010PubMedCentralCrossRefPubMed Pelz RK, Hendrix CW, Swoboda SM, Diener-West M, Merz WG, Hammond J, Lipsett PA: Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg 2001, 233: 542-548. 10.1097/00000658-200104000-00010PubMedCentralCrossRefPubMed
12.
go back to reference Eggimann P, Francioli P, Bille J, Schneider R, Wu MM, Chapuis G, Chiolero R, Pannatier A, Schilling J, Geroulanos S, Glauser MP, Calandra T: Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 1999, 27: 1066-1072. 10.1097/00003246-199906000-00019CrossRefPubMed Eggimann P, Francioli P, Bille J, Schneider R, Wu MM, Chapuis G, Chiolero R, Pannatier A, Schilling J, Geroulanos S, Glauser MP, Calandra T: Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 1999, 27: 1066-1072. 10.1097/00003246-199906000-00019CrossRefPubMed
13.
go back to reference ARDS Network: Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. The ARDS Network. JAMA 2000, 283: 1995-2002. 10.1001/jama.283.15.1995CrossRef ARDS Network: Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. The ARDS Network. JAMA 2000, 283: 1995-2002. 10.1001/jama.283.15.1995CrossRef
14.
go back to reference Savino JA, Agarwal N, Wry P, Policastro A, Cerabona T, Austria L: Routine prophylactic antifungal agents (clotrimazole, ketoconazole, and nystatin) in nontransplant/nonburned critically ill surgical and trauma patients. J Trauma 1994, 36: 20-26. 10.1097/00005373-199401000-00004CrossRefPubMed Savino JA, Agarwal N, Wry P, Policastro A, Cerabona T, Austria L: Routine prophylactic antifungal agents (clotrimazole, ketoconazole, and nystatin) in nontransplant/nonburned critically ill surgical and trauma patients. J Trauma 1994, 36: 20-26. 10.1097/00005373-199401000-00004CrossRefPubMed
15.
go back to reference Yu M, Tomasa G: A double-blind, prospective, randomized trial of ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome. Crit Care Med 1993, 21: 1635-1642. 10.1097/00003246-199311000-00010CrossRefPubMed Yu M, Tomasa G: A double-blind, prospective, randomized trial of ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome. Crit Care Med 1993, 21: 1635-1642. 10.1097/00003246-199311000-00010CrossRefPubMed
16.
go back to reference Slotman GJ, Burchard KW: Ketoconazole prevents Candida sepsis in critically ill surgical patients. Arch Surg 1987, 122: 147-151. 10.1001/archsurg.1987.01400140029002CrossRefPubMed Slotman GJ, Burchard KW: Ketoconazole prevents Candida sepsis in critically ill surgical patients. Arch Surg 1987, 122: 147-151. 10.1001/archsurg.1987.01400140029002CrossRefPubMed
17.
go back to reference Playford EG, Webster AC, Sorrell TC, Craig JC: Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients. Cochrane Database Syst Rev 2006,2006(1):CD004920. Playford EG, Webster AC, Sorrell TC, Craig JC: Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients. Cochrane Database Syst Rev 2006,2006(1):CD004920.
18.
go back to reference Playford EG, Webster AC, Sorrell TC, Craig JC: Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials. J Antimicrob Chemother 2006, 57: 628-638. 10.1093/jac/dki491CrossRefPubMed Playford EG, Webster AC, Sorrell TC, Craig JC: Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials. J Antimicrob Chemother 2006, 57: 628-638. 10.1093/jac/dki491CrossRefPubMed
19.
go back to reference Vardakas KZ, Samonis G, Michalopoulos A, Soteriades ES, Falagas ME: Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials. Crit Care Med 2006, 34: 1216-1224. 10.1097/01.CCM.0000208357.05675.C3CrossRefPubMed Vardakas KZ, Samonis G, Michalopoulos A, Soteriades ES, Falagas ME: Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials. Crit Care Med 2006, 34: 1216-1224. 10.1097/01.CCM.0000208357.05675.C3CrossRefPubMed
20.
go back to reference Ho KM, Lipman J, Dobb GJ, Webb SA: The use of prophylactic fluconazole in immunocompetent high-risk surgical patients: a meta-analysis. Crit Care 2005, 9: R710-R717. 10.1186/cc3883PubMedCentralCrossRefPubMed Ho KM, Lipman J, Dobb GJ, Webb SA: The use of prophylactic fluconazole in immunocompetent high-risk surgical patients: a meta-analysis. Crit Care 2005, 9: R710-R717. 10.1186/cc3883PubMedCentralCrossRefPubMed
21.
go back to reference Cruciani M, de Lalla F, Mengoli C: Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: a systematic review and meta-analysis. Intensive Care Med 2005, 31: 1479-1487. 10.1007/s00134-005-2794-yCrossRefPubMed Cruciani M, de Lalla F, Mengoli C: Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: a systematic review and meta-analysis. Intensive Care Med 2005, 31: 1479-1487. 10.1007/s00134-005-2794-yCrossRefPubMed
22.
go back to reference Shorr AF, Chung K, Jackson WL, Waterman PE, Kollef MH: Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis. Crit Care Med 2005, 33: 1928-1936. 10.1097/01.CCM.0000178352.14703.49CrossRefPubMed Shorr AF, Chung K, Jackson WL, Waterman PE, Kollef MH: Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis. Crit Care Med 2005, 33: 1928-1936. 10.1097/01.CCM.0000178352.14703.49CrossRefPubMed
23.
go back to reference Downs SH, Black N: The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998, 52: 377-384. 10.1136/jech.52.6.377PubMedCentralCrossRefPubMed Downs SH, Black N: The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998, 52: 377-384. 10.1136/jech.52.6.377PubMedCentralCrossRefPubMed
24.
go back to reference Harrell FE Jr, Lee KL, Mark DB: Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996, 15: 361-387. 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4CrossRefPubMed Harrell FE Jr, Lee KL, Mark DB: Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996, 15: 361-387. 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4CrossRefPubMed
25.
go back to reference Mallett S, Royston P, Dutton S, Waters R, Altman DG: Reporting methods in studies developing prognostic models in cancer: a review. BMC Med 2010, 8: 20. 10.1186/1741-7015-8-20PubMedCentralCrossRefPubMed Mallett S, Royston P, Dutton S, Waters R, Altman DG: Reporting methods in studies developing prognostic models in cancer: a review. BMC Med 2010, 8: 20. 10.1186/1741-7015-8-20PubMedCentralCrossRefPubMed
26.
go back to reference Jordà-Marcos R, Alvarez-Lerma F, Jurado M, Palomar M, Nolla-Salas J, León MA, León C, EPCAN Study Group: Risk factors for candidaemia in critically ill patients: a prospective surveillance study. Mycoses 2007, 50: 302-310. 10.1111/j.1439-0507.2007.01366.xCrossRefPubMed Jordà-Marcos R, Alvarez-Lerma F, Jurado M, Palomar M, Nolla-Salas J, León MA, León C, EPCAN Study Group: Risk factors for candidaemia in critically ill patients: a prospective surveillance study. Mycoses 2007, 50: 302-310. 10.1111/j.1439-0507.2007.01366.xCrossRefPubMed
27.
go back to reference León C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, Alvarez-Lerma F, Garnacho-Montero J, León MA, EPCAN Study Group: A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 2006, 34: 730-737. 10.1097/01.CCM.0000202208.37364.7DCrossRefPubMed León C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, Alvarez-Lerma F, Garnacho-Montero J, León MA, EPCAN Study Group: A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 2006, 34: 730-737. 10.1097/01.CCM.0000202208.37364.7DCrossRefPubMed
28.
go back to reference Agvald-Ohman C, Klingspor L, Hjelmqvist H, Edlund C: Invasive candidiasis in long-term patients at a multidisciplinary intensive care unit: Candida colonization index, risk factors, treatment and outcome. Scand J Infect Dis 2008, 40: 145-153. 10.1080/00365540701534509CrossRefPubMed Agvald-Ohman C, Klingspor L, Hjelmqvist H, Edlund C: Invasive candidiasis in long-term patients at a multidisciplinary intensive care unit: Candida colonization index, risk factors, treatment and outcome. Scand J Infect Dis 2008, 40: 145-153. 10.1080/00365540701534509CrossRefPubMed
29.
go back to reference Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA, Rangel-Frausto MS, Rinaldi MG, Saiman L, Wiblin RT, Wenzel RP, National Epidemiology of Mycoses Survey(NEMIS) Study Group: Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 2001, 33: 177-186. 10.1086/321811CrossRefPubMed Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA, Rangel-Frausto MS, Rinaldi MG, Saiman L, Wiblin RT, Wenzel RP, National Epidemiology of Mycoses Survey(NEMIS) Study Group: Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 2001, 33: 177-186. 10.1086/321811CrossRefPubMed
30.
go back to reference Chow JK, Golan Y, Ruthazer R, Karchmer AW, Carmeli Y, Lichtenberg DA, Chawla V, Young JA, Hadley S: Risk factors for albicans and non- albicans candidemia in the intensive care unit. Crit Care Med 2008, 36: 1993-1998. 10.1097/CCM.0b013e31816fc4cdCrossRefPubMed Chow JK, Golan Y, Ruthazer R, Karchmer AW, Carmeli Y, Lichtenberg DA, Chawla V, Young JA, Hadley S: Risk factors for albicans and non- albicans candidemia in the intensive care unit. Crit Care Med 2008, 36: 1993-1998. 10.1097/CCM.0b013e31816fc4cdCrossRefPubMed
31.
go back to reference Ibàñez-Nolla J, Nolla-Salas M, León MA, García F, Marrugat J, Soria G, Díaz RM, Torres-Rodríguez JM: Early diagnosis of candidiasis in non-neutropenic critically ill patients. J Infect 2004, 48: 181-192. 10.1016/S0163-4453(03)00120-8CrossRefPubMed Ibàñez-Nolla J, Nolla-Salas M, León MA, García F, Marrugat J, Soria G, Díaz RM, Torres-Rodríguez JM: Early diagnosis of candidiasis in non-neutropenic critically ill patients. J Infect 2004, 48: 181-192. 10.1016/S0163-4453(03)00120-8CrossRefPubMed
32.
go back to reference McKinnon PS, Goff DA, Kern JW, Devlin JW, Barletta JF, Sierawski SJ, Mosenthal AC, Gore P, Ambegaonkar AJ, Lubowski TJ: Temporal assessment of Candida risk factors in the surgical intensive care unit. Arch Surg 2001, 136: 1401-1408. 10.1001/archsurg.136.12.1401CrossRefPubMed McKinnon PS, Goff DA, Kern JW, Devlin JW, Barletta JF, Sierawski SJ, Mosenthal AC, Gore P, Ambegaonkar AJ, Lubowski TJ: Temporal assessment of Candida risk factors in the surgical intensive care unit. Arch Surg 2001, 136: 1401-1408. 10.1001/archsurg.136.12.1401CrossRefPubMed
33.
go back to reference Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R: Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994, 220: 751-758. 10.1097/00000658-199412000-00008PubMedCentralCrossRefPubMed Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R: Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994, 220: 751-758. 10.1097/00000658-199412000-00008PubMedCentralCrossRefPubMed
34.
go back to reference Borzotta AP, Beardsley K: Candida infections in critically ill trauma patients: a retrospective case-control study. Arch Surg 1999, 134: 657-664. 10.1001/archsurg.134.6.657CrossRefPubMed Borzotta AP, Beardsley K: Candida infections in critically ill trauma patients: a retrospective case-control study. Arch Surg 1999, 134: 657-664. 10.1001/archsurg.134.6.657CrossRefPubMed
35.
go back to reference Paphitou NI, Ostrosky-Zeichner L, Rex JH: Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials. Med Mycol 2005, 43: 235-243. 10.1080/13693780410001731619CrossRefPubMed Paphitou NI, Ostrosky-Zeichner L, Rex JH: Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials. Med Mycol 2005, 43: 235-243. 10.1080/13693780410001731619CrossRefPubMed
36.
go back to reference Michalopoulos AS, Geroulanos S, Mentzelopoulos SD: Determinants of candidemia and candidemia-related death in cardiothoracic ICU patients. Chest 2003, 124: 2244-2255. 10.1378/chest.124.6.2244CrossRefPubMed Michalopoulos AS, Geroulanos S, Mentzelopoulos SD: Determinants of candidemia and candidemia-related death in cardiothoracic ICU patients. Chest 2003, 124: 2244-2255. 10.1378/chest.124.6.2244CrossRefPubMed
37.
go back to reference Ostrosky-Zeichner L, Sable C, Sobel J, Alexander BD, Donowitz G, Kan V, Kauffman CA, Kett D, Larsen RA, Morrison V, Nucci M, Pappas PG, Bradley ME, Major S, Zimmer L, Wallace D, Dismukes WE, Rex JH: Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 2007, 26: 271-276. 10.1007/s10096-007-0270-zCrossRefPubMed Ostrosky-Zeichner L, Sable C, Sobel J, Alexander BD, Donowitz G, Kan V, Kauffman CA, Kett D, Larsen RA, Morrison V, Nucci M, Pappas PG, Bradley ME, Major S, Zimmer L, Wallace D, Dismukes WE, Rex JH: Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 2007, 26: 271-276. 10.1007/s10096-007-0270-zCrossRefPubMed
38.
go back to reference Piarroux R, Grenouillet F, Balvay P, Tran V, Blasco G, Millon L, Boillot A: Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients. Crit Care Med 2004, 32: 2443-2449. 10.1097/01.CCM.0000147726.62304.7FCrossRefPubMed Piarroux R, Grenouillet F, Balvay P, Tran V, Blasco G, Millon L, Boillot A: Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients. Crit Care Med 2004, 32: 2443-2449. 10.1097/01.CCM.0000147726.62304.7FCrossRefPubMed
39.
go back to reference Steyerberg EW, Eijkemans MJ, Habbema JD: Stepwise selection in small data sets: a simulation study of bias in logistic regression analysis. J Clin Epidemiol 1999, 52: 935-942. 10.1016/S0895-4356(99)00103-1CrossRefPubMed Steyerberg EW, Eijkemans MJ, Habbema JD: Stepwise selection in small data sets: a simulation study of bias in logistic regression analysis. J Clin Epidemiol 1999, 52: 935-942. 10.1016/S0895-4356(99)00103-1CrossRefPubMed
40.
go back to reference León C, Ruiz-Santana S, Saavedra P, Galván B, Blanco A, Castro C, Balasini C, Utande-Vázquez A, González de Molina FJ, Blasco-Navalproto MA, López MJ, Charles PE, Martín E, Hernández-Viera MA, Cava Study Group: Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med 2009, 37: 1624-1633. 10.1097/CCM.0b013e31819daa14CrossRefPubMed León C, Ruiz-Santana S, Saavedra P, Galván B, Blanco A, Castro C, Balasini C, Utande-Vázquez A, González de Molina FJ, Blasco-Navalproto MA, López MJ, Charles PE, Martín E, Hernández-Viera MA, Cava Study Group: Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med 2009, 37: 1624-1633. 10.1097/CCM.0b013e31819daa14CrossRefPubMed
41.
go back to reference Playford EG, Lipman J, Kabir M, McBryde ES, Nimmo GR, Lau A, Sorrell TC: Assessment of clinical risk predictive rules for invasive candidiasis in a prospective multicentre cohort of ICU patients. Intensive Care Med 2009, 35: 2141-2145. 10.1007/s00134-009-1619-9CrossRefPubMed Playford EG, Lipman J, Kabir M, McBryde ES, Nimmo GR, Lau A, Sorrell TC: Assessment of clinical risk predictive rules for invasive candidiasis in a prospective multicentre cohort of ICU patients. Intensive Care Med 2009, 35: 2141-2145. 10.1007/s00134-009-1619-9CrossRefPubMed
42.
go back to reference Hermsen ED, Zapapas MK, Maiefski M, Rupp ME, Freifeld AG, Kalil AC: Validation and comparison of clinical prediction rules for invasive candidiasis in intensive care unit patients: a matched case-control study. Crit Care 2011, 15: R198. 10.1186/cc10366PubMedCentralCrossRefPubMed Hermsen ED, Zapapas MK, Maiefski M, Rupp ME, Freifeld AG, Kalil AC: Validation and comparison of clinical prediction rules for invasive candidiasis in intensive care unit patients: a matched case-control study. Crit Care 2011, 15: R198. 10.1186/cc10366PubMedCentralCrossRefPubMed
Metadata
Title
Risk factors for invasive fungal disease in critically ill adult patients: a systematic review
Authors
Hannah Muskett
Jason Shahin
Gavin Eyres
Sheila Harvey
Kathy Rowan
David Harrison
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Critical Care / Issue 6/2011
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc10574

Other articles of this Issue 6/2011

Critical Care 6/2011 Go to the issue